PT84075B - Processo para a preparacao de derivados de indol - Google Patents

Processo para a preparacao de derivados de indol

Info

Publication number
PT84075B
PT84075B PT84075A PT8407587A PT84075B PT 84075 B PT84075 B PT 84075B PT 84075 A PT84075 A PT 84075A PT 8407587 A PT8407587 A PT 8407587A PT 84075 B PT84075 B PT 84075B
Authority
PT
Portugal
Prior art keywords
preparation
indole derivatives
indole
derivatives
Prior art date
Application number
PT84075A
Other languages
English (en)
Other versions
PT84075A (en
Inventor
Michael Dennis Dowle
Colin David Eldred
David Edmund Bays
Ian Harold Coates
Alexander William Oxford
Keith Mills
Colin Frederick Webb
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of PT84075A publication Critical patent/PT84075A/pt
Publication of PT84075B publication Critical patent/PT84075B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C07D209/16—Tryptamines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
PT84075A 1986-01-08 1987-01-08 Processo para a preparacao de derivados de indol PT84075B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB868600397A GB8600397D0 (en) 1986-01-08 1986-01-08 Chemical compounds

Publications (2)

Publication Number Publication Date
PT84075A PT84075A (en) 1987-02-01
PT84075B true PT84075B (pt) 1989-07-31

Family

ID=10591074

Family Applications (1)

Application Number Title Priority Date Filing Date
PT84075A PT84075B (pt) 1986-01-08 1987-01-08 Processo para a preparacao de derivados de indol

Country Status (23)

Country Link
US (1) US4855314A (pt)
EP (1) EP0240096A1 (pt)
JP (1) JPS62228056A (pt)
KR (1) KR870007116A (pt)
CN (1) CN1030409A (pt)
AU (1) AU597325B2 (pt)
BE (1) BE1000071A4 (pt)
CH (1) CH672637A5 (pt)
DE (1) DE3700408A1 (pt)
DK (1) DK8787A (pt)
FI (1) FI870062A (pt)
FR (1) FR2595351B1 (pt)
GB (2) GB8600397D0 (pt)
HU (1) HU198685B (pt)
IL (1) IL81201A (pt)
IT (1) IT1205849B (pt)
LU (1) LU86732A1 (pt)
NL (1) NL8700026A (pt)
NO (1) NO870075L (pt)
NZ (1) NZ218868A (pt)
PH (1) PH24741A (pt)
PT (1) PT84075B (pt)
ZA (1) ZA87105B (pt)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8530507D0 (en) * 1985-12-11 1986-01-22 Glaxo Group Plc Chemical compounds
GB8600398D0 (en) * 1986-01-08 1986-02-12 Glaxo Group Ltd Chemical compounds
GB8724912D0 (en) 1987-10-23 1987-11-25 Wellcome Found Indole derivatives
US5225431A (en) * 1987-10-23 1993-07-06 Burroughs Wellcome Co. Therapeutic substituted indole compounds and compositions thereof
GB8819024D0 (en) * 1988-08-10 1988-09-14 Glaxo Group Ltd Chemical compounds
GB8823731D0 (en) * 1988-10-10 1988-11-16 Smith Kline French Lab Biologically active compounds
MC2210A1 (fr) * 1990-06-07 1992-11-26 Wellcome Found Composes heterocycliques therapeutiques,leur utilisation et procede pour les preparer
US5545644A (en) * 1990-10-15 1996-08-13 Pfizer Inc. Indole derivatives
US5607951A (en) * 1990-10-15 1997-03-04 Pfizer Inc Indole derivatives
US5578612A (en) * 1990-10-15 1996-11-26 Pfizer Inc. Indole derivatives
US5559129A (en) * 1990-10-15 1996-09-24 Pfizer Inc Indole derivatives
DE9190141U1 (de) * 1990-10-15 1993-07-15 Pfizer Inc., New York, N.Y. Indolderivate
US5559246A (en) * 1990-10-15 1996-09-24 Pfizer Inc. Indole derivatives
CA2061520C (en) * 1991-03-27 2003-04-22 Lawrence J. Daher Delivery system for enhanced onset and increased potency
ES2143992T3 (es) * 1991-11-25 2000-06-01 Pfizer Derivados de 5-(hetero- o carbociclilamino)-indol, su preparacion y uso como 5-ht1 agonistas.
TW288010B (pt) * 1992-03-05 1996-10-11 Pfizer
US6380233B1 (en) 1992-04-07 2002-04-30 Pfizer Inc Indole derivatives as 5-HT1 agonists
UA27467C2 (uk) 1992-04-07 2000-09-15 Пфайзер Інк. ПОХІДНІ ІНДОЛУ ЯК 5-НТ<sub>1</sub> АГОНІСТИ ТА ПРОМІЖНІ СПОЛУКИ
AU670270B2 (en) * 1992-04-10 1996-07-11 Pfizer Inc. Acylaminoindole derivatives as 5-HT1 agonists
GB9207930D0 (en) * 1992-04-10 1992-05-27 Pfizer Ltd Indoles
GB9211277D0 (en) 1992-05-28 1992-07-15 Glaxo Group Inc Pharmaceutical compositions
TW251284B (pt) * 1992-11-02 1995-07-11 Pfizer
FR2707639B1 (fr) * 1993-06-30 1995-10-13 Pf Medicament Nouveaux composés indoliques dérivés d'arylamines comme ligands sélectifs des récepteurs 5HT1D et 5HT1B.
ES2070772B1 (es) * 1993-08-09 1996-02-16 Pfizer Derivados de acilaminoindol
US5849739A (en) * 1993-08-31 1998-12-15 Pfizer Inc. 5-arylindole derivatives
US5468768A (en) * 1994-01-06 1995-11-21 Bristol-Myers Squibb Company Antimigraine derivatives of indolylcycloalkanylamines
GB9417310D0 (en) 1994-08-27 1994-10-19 Pfizer Ltd Therapeutic agents
FR2749846B1 (fr) * 1996-06-17 1998-09-11 Pf Medicament Sel de methanesulfonate d'une arylpiperazine derivee de tryptamine et ses solvates pour usage pharmaceutique
US5994352A (en) * 1998-11-13 1999-11-30 Pfizer Inc. 5-arylindole derivatives
ATE328868T1 (de) * 2000-08-21 2006-06-15 Pacific Corp Neue (thio)harnstoffverbindungen und arzneimittelkompositionen, die diese enthalten
DE60329607D1 (de) * 2002-06-21 2009-11-19 Suven Life Sciences Ltd Sich als therapeutische mittel eignende arylalkylindole mit affinität für den serotoninrezeptor, verfahren zu deren herstellung und pharmazeutische zusammensetzungen, die diese enthalten
BR0312174A (pt) 2002-06-21 2005-04-05 Suven Life Sciences Ltd Composto, composição farmacêutica, uso de um composto, método para o tratamento, método para reduzir a morbidez e a mortalidade associadas com o excesso de peso, processo para a preparação de um composto, novo intermediário e processo para a preparação de um novo intermediário
CN100378108C (zh) * 2002-06-21 2008-04-02 苏文生命科学有限公司 对血清素受体具有亲和力、可用作治疗剂的新型四环芳基磺酰吲哚、其制备方法及其药物组合物
WO2004048328A2 (en) 2002-11-28 2004-06-10 Suven Life Sciences Limited N-arylsulfonyl-3-aminoalkoxyindoles
AU2003237599B2 (en) * 2002-11-28 2009-06-18 Suven Life Sciences Limited N-arylsulfonyl-3-substituted indoles having serotonin receptor affinity, process for their preparation and pharmaceutical composition containing them
EP1581538B1 (en) * 2002-12-18 2007-02-28 Suven Life Sciences Limited Tetracyclic 3-substituted indoles having serotonin receptor affinity
CA2508290C (en) * 2002-12-20 2017-02-28 Ciba Specialty Chemicals Holding Inc. Synthesis of amines and intermediates for the synthesis thereof
AU2007257882B2 (en) * 2006-06-12 2011-09-08 Secura Bio Inc. Process for making salts of N-hydroxy-3-[4-[[[2-(2-methyl-1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2E-2-propenamide

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3472870A (en) * 1966-08-29 1969-10-14 Mead Johnson & Co Sulfonamidotryptamines
FR2334358A1 (fr) * 1975-12-12 1977-07-08 Sogeras Nouveaux medicaments derives de l'indole
ZA795239B (en) * 1978-10-12 1980-11-26 Glaxo Group Ltd Heterocyclic compounds
ZW19381A1 (en) * 1980-08-12 1983-03-09 Glaxo Group Ltd Heterocyclic compounds
ES504694A0 (es) * 1980-08-12 1982-11-01 Glaxo Group Ltd Procedimiento para la preparacion de derivados del indol.
GB8332435D0 (en) * 1983-12-06 1984-01-11 Glaxo Group Ltd Chemical compounds
GB8332434D0 (en) * 1983-12-06 1984-01-11 Glaxo Group Ltd Production of chemical compounds
GB8332437D0 (en) * 1983-12-06 1984-01-11 Glaxo Group Ltd Chemical compounds
GB8600398D0 (en) * 1986-01-08 1986-02-12 Glaxo Group Ltd Chemical compounds

Also Published As

Publication number Publication date
FI870062A0 (fi) 1987-01-08
HUT46891A (en) 1988-12-28
LU86732A1 (fr) 1988-02-02
DE3700408A1 (de) 1987-07-09
PH24741A (en) 1990-10-01
DK8787D0 (da) 1987-01-08
IT1205849B (it) 1989-03-31
CN1030409A (zh) 1989-01-18
IL81201A0 (en) 1987-08-31
CH672637A5 (pt) 1989-12-15
DK8787A (da) 1987-07-09
GB8700382D0 (en) 1987-02-11
EP0240096A1 (en) 1987-10-07
NL8700026A (nl) 1987-08-03
NZ218868A (en) 1990-04-26
GB2185020B (en) 1990-05-16
GB2185020A (en) 1987-07-08
ZA87105B (en) 1987-09-30
US4855314A (en) 1989-08-08
FR2595351A1 (fr) 1987-09-11
BE1000071A4 (fr) 1988-02-02
NO870075D0 (no) 1987-01-08
GB8600397D0 (en) 1986-02-12
KR870007116A (ko) 1987-08-14
JPS62228056A (ja) 1987-10-06
FR2595351B1 (fr) 1990-07-13
AU597325B2 (en) 1990-05-31
IL81201A (en) 1991-06-10
AU6742087A (en) 1987-07-09
IT8747507A0 (it) 1987-01-08
HU198685B (en) 1989-11-28
PT84075A (en) 1987-02-01
NO870075L (no) 1987-07-09
FI870062A (fi) 1987-07-09

Similar Documents

Publication Publication Date Title
PT84075B (pt) Processo para a preparacao de derivados de indol
ES557483A0 (es) Un procedimiento para la preparacion de derivados de indol
PT81859B (pt) Processo para a preparacao de derivados de tiazolidinodionas
DK3587A (da) Indolforbindelser
ES546631A0 (es) Un procedimiento para la preparacion de derivados de indol
PT83876B (pt) Processo para a preparacao de derivados de butiramida n-substituidos
PT82710B (pt) Processo para a preparacao de derivados la-7-substituidos de mitomicina
PT87707A (pt) Processo para a preparacao de derivados de 2-anilino-pirimidina
PT84561B (pt) Processo aperfeicoado para a preparacao de derivados macrolidos
PT86687A (pt) Process for the preparation of novel polyamine derivatives
DK134687D0 (da) Indolderivater
PT83418B (pt) Processo para a preparacao de derivados de analogos de mitomicina c
BR8702112A (pt) Processo para a preparacao de um derivado de pirazol pirimidina
PT88181A (pt) Processo para a preparacao de derivados aralquilaminoalcoxifenilo
PT89775A (pt) Processo para a preparacao de derivados de isoquinolina
PT92539A (pt) Processo para a preparacao de derivados de anfotericina b
BR8706915A (pt) Processo para a preparacao de derivados metoxibenzofenona,metoxibenzofenonas e composto
PT84459B (pt) Processo para a preparacao de derivados de ciclopropano 1,1-dissubstituidos
ES552910A0 (es) Un procedimiento para preparar derivados de indol
BR8700457A (pt) Processo para a preparacao de um derivado de alquileno-diamina
PT85608A (pt) Processo para a preparacao de derivados de fenil-etanolamina
PT89778A (pt) Processo para a preparacao de um derivado de hirudina
PT88924A (pt) Processo para a preparacao de derivados de ginkgolidos
PT84100B (pt) Processo para a preparacao de derivados fluorados diaminoalcinicos
PT82471B (pt) Processo para a preparacao de derivados de mitomicina c n7-amidino-substituida

Legal Events

Date Code Title Description
MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 19920731